Authors
Latest:
Climbing Health Care Costs Result in Elevated Employer VigilanceSoaring healthcare costs show little sign of abating in 2024, and concerns about the affordability of medications and medical services continue to grow, despite investments in technology, clinical innovation, and efforts to manage utilization and waste.
Latest:
Strategic EPCIS Implementation: Optimizing Supply Chain Management through Strategic EPCIS ImplementationThis document outlines key strategies and testing protocols critical for optimizing EPCIS implementation, ensuring that pharmaceutical manufacturers can maintain compliance and operational efficiency.
Latest:
What Your Data Can Tell You About Illicit Trade RiskWhy taking proactive steps—and combing the right data sources—is critical to informed decision-making in risk management.
Latest:
Pharmaceutical Cold Chain Logistics in the Age of Artificial IntelligenceBuilding strategy, mitigating risk, and achieving success with artificial intelligence.
Latest:
Preparing for the Growth of Cold ChainCardinal Health helps create a more predictable and efficient supply chain by investing in the future of cold-chain storage and transportation.
Latest:
The Promise of RFID for Improving Medication Inventory ManagementRadio frequency identification (RFID) not only helps hospitals boost their medication safety standards, it also allows clinicians to continue to provide quality patient care.
Latest:
The Future State of Oncology: The Rise of Oncology Home CareWhile there are still hurdles to overcome along the way, home healthcare could deliver better patient-centered cancer care, providing improved patient outcomes, enhanced quality of life, and reduced strain on resources.
Latest:
What Do Pharmaceutical Manufacturers Actually Want Most from a Hub?Among a variety of Hub vendors, what specific qualities distinguish differentiated support for drug manufacturers? To help answer this question, CareMetx conducted in-depth interviews and surveys with senior leadership at top manufacturers.
Latest:
New Serialization Mandates Inch CloserPressure is mounting ahead of looming unit-level serialization required by the Drug Supply Chain Security Act—necessitating a wide scope of collaboration on compliance
Latest:
Operating Without a Commercial Blueprint: Empowering the Field for Niche Therapy LaunchesHow emerging biotech companies can create fruitful partnerships between home office commercial teams and the field force to enable this intelligence gathering, while driving commercial success.
Latest:
Evaluating Patient Support Programs: Opportunities and PitfallsAssessing the efficacy of patient support programs is the first step to optimizing their resource allocation and program design for maximized patient benefit.
Latest:
Key Supply Chain Tech Trends for 2023Outlining those advances poised to drive increased use of integrated tactical planning (ITP) in helping manufacturers overcome persistent supply chain obstacles.
Latest:
Technically Speaking: Quality Documentation is One of the Best Ways to Boost PerformanceWhy well-organized documentation is critical at every stage of the process.
Latest:
Asembia 2025: How Specialty Pharmacies Are Evolving to Support Rare ConditionsWill Pih, co-founder, Two Labs, explains how specialty pharmacies and manufacturers are adapting to financial pressures in rare disease care through patient-centric services, hub innovation, and hybrid technology models.
Latest:
The Impact of Serialization Technology: Ensuring Product Integrity and Regulatory ComplianceThese advancements continue to act as a key driver in helping to boost the security, efficiency, and innovation of global industries, include pharma.
Latest:
A Game Changer for Commercial Insights?Configuration-driven SaaS, powered by modern data management technology, can enable orphan drug manufacturers to form effective commercial strategies
Latest:
Specialty access barriers: How technology can help2020 was a difficult year for many patients, but new data may signal a brighter future ahead
Latest:
Medicine for the Planet: Building a Sustainable Legacy in Pharma Supply ChainsNew innovations that are contributing to industry environmental efforts.
Latest:
How Healthcare Economics Outcomes Evidence Can Pave the Way for Digital TherapeuticsIn the face of chronic disease, DTx have the opportunity to provide a lifeline to patients.
Latest:
Exclusivity Creates Challenges in Price, Access for Long-used MedicationsFDA’s Unapproved Drug Initiative (UDI) is a well-intentioned program in its encouragement of formal FDA review for unapproved legacy medications. But it has inadvertently created financial challenges and access issues, write Steven Lucio and Jenna Stern
Latest:
Health policies high on specialty radar in 2021The key trends and considerations for specialty providers navigating a changing policy landscape
Latest:
Revolutionizing Rare Disease Treatment: Embracing the Patient-Centric Transformation in Pharmaceutical Customer EngagementNavigating the complex landscape of healthcare coverage can be an intimidating task, especially for patients with rare diseases for which treatments often come with a high price tag.
Latest:
Critical Year Ahead for the 340B Drug Pricing ProgramThe courts reversed certain key guidance documents issued by the Health Resources and Services Administration for the 340B Program, which raises uncertainty.
Latest:
Navigating the Biosimilars MarketplaceHow to provide effective brand engagement in this rocky yet emerging landscape.
Latest:
Future of Personalized Medicine Hinges on Pharma Executives Revolutionizing Business ModelsThe era of big pharma as product-first companies must end, as services become the larger priority.
Latest:
Applying AI Case Studies in PharmaHow artificial intelligence and real-world data has not just helped predict patient behavior, but has also been successful at the point-of-care for life sciences companies.
Latest:
Medical Affairs Role in Shaping StrategyWhat the Changing Healthcare Landscape Demands of Future MA Professionals?
